These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Anti-arrhythmia therapy after myocardial infarct: preliminary results of EMIAT and CAMIAT studies]. Kuck KH Z Kardiol; 1996; 85 Suppl 6():107-13. PubMed ID: 9064953 [TBL] [Abstract][Full Text] [Related]
4. [Management of patients with risk of sudden death. The amiodarone example]. Djian J Arch Mal Coeur Vaiss; 1994 Jan; 87(1 Spec No):67-74. PubMed ID: 7944868 [TBL] [Abstract][Full Text] [Related]
5. Usefulness of ventricular repolarization dynamicity in predicting arrhythmic deaths in patients with ischemic cardiomyopathy (from the European Myocardial Infarct Amiodarone Trial). Milliez P; Leenhardt A; Maisonblanche P; Vicaut E; Badilini F; Siliste C; Benchetrit C; Coumel P; Am J Cardiol; 2005 Apr; 95(7):821-6. PubMed ID: 15781008 [TBL] [Abstract][Full Text] [Related]
6. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators. Julian DG; Camm AJ; Frangin G; Janse MJ; Munoz A; Schwartz PJ; Simon P Lancet; 1997 Mar; 349(9053):667-74. PubMed ID: 9078197 [TBL] [Abstract][Full Text] [Related]
7. Does amiodarone reduce sudden death and cardiac mortality after myocardial infarction? The European Myocardial Infarct Amiodarone Trial (EMIAT). Schwartz PJ; Camm AJ; Frangin G; Janse MJ; Julian DG; Simon P Eur Heart J; 1994 May; 15(5):620-4. PubMed ID: 8056000 [No Abstract] [Full Text] [Related]
8. Long-term amiodarone therapy and the risk of complications after cardiac surgery: results from the Canadian Amiodarone Myocardial Infarction Arrhythmia Trial (CAMIAT). Crystal E; Kahn S; Roberts R; Thorpe K; Gent M; Cairns JA; Dorian P; Connolly SJ J Thorac Cardiovasc Surg; 2003 Mar; 125(3):633-7. PubMed ID: 12658206 [TBL] [Abstract][Full Text] [Related]
9. Amiodarone in high-risk post-infarction patients, Lessons from EMIAT and CAMIAT. European Myocardial Infarct Amiodarone Trial and Canadian Amiodarone Myocardial Infarction Arrhythmia Trial. Gambhir DS Indian Heart J; 1996; 48(4):339-41. PubMed ID: 8908817 [No Abstract] [Full Text] [Related]
10. The Midlands Trial of Empirical Amiodarone versus Electrophysiology-guided Interventions and Implantable Cardioverter-defibrillators (MAVERIC): a multi-centre prospective randomised clinical trial on the secondary prevention of sudden cardiac death. Lau EW; Griffith MJ; Pathmanathan RK; Ng GA; Clune MM; Cooper J; Marshall HJ; Forsey PR; Stafford PJ; Gray RG; Skehan JD; Garratt CJ Europace; 2004 Jul; 6(4):257-66. PubMed ID: 15172648 [TBL] [Abstract][Full Text] [Related]
11. [Prolongation of the CAST study.Is it justified to consider another trial?]. Lekieffre J; Kacet S; Caron J; Lacroix D; Libersa C Arch Mal Coeur Vaiss; 1991 Feb; 84 Spec No 2():71-4. PubMed ID: 1669241 [TBL] [Abstract][Full Text] [Related]
12. [Rationale, characteristics and study design of PREAMI (Perindopril and Remodelling in the Elderly with Acute Myocardial Infraction)]. Magrini G; Nicolosi GL; Chiariello M; Ferrari R; Remme P; Tavazzi L Ital Heart J; 2005 Nov; 6 Suppl 7():14S-23S. PubMed ID: 16485513 [TBL] [Abstract][Full Text] [Related]
13. Prevalent low-frequency oscillation of heart rate: novel predictor of mortality after myocardial infarction. Wichterle D; Simek J; La Rovere MT; Schwartz PJ; Camm AJ; Malik M Circulation; 2004 Sep; 110(10):1183-90. PubMed ID: 15313954 [TBL] [Abstract][Full Text] [Related]
14. Prognostic factors affecting the all-cause death and sudden cardiac death rates of post myocardial infarction patients with low left ventricular ejection fraction. Dai SM; Zhang S; Chen KP; Hua W; Wang FZ; Chen X Chin Med J (Engl); 2009 Apr; 122(7):802-6. PubMed ID: 19493393 [TBL] [Abstract][Full Text] [Related]
15. The European Myocardial Infarct Amiodarone Trial (EMIAT). EMIAT Investigators. Camm AJ; Julian D; Janse G; Munoz A; Schwartz P; Simon P; Frangin G Am J Cardiol; 1993 Nov; 72(16):95F-98F. PubMed ID: 8237837 [TBL] [Abstract][Full Text] [Related]
16. [Multicenter clinical trial on the prevention of sudden death after myocardial infarction by the use of anti-arrhythmia agents. Investigator Group of the Spanish Study on Sudden Death]. Rev Esp Cardiol; 1989 Feb; 42(2):77-83. PubMed ID: 2675221 [TBL] [Abstract][Full Text] [Related]
17. [Trandolapril in patients with left ventricular insufficiency after myocardial infarction]. Aliot E Arch Mal Coeur Vaiss; 1996 Aug; 89 Spec No 3():23-31. PubMed ID: 8949315 [TBL] [Abstract][Full Text] [Related]
18. Depressed heart rate variability identifies postinfarction patients who might benefit from prophylactic treatment with amiodarone: a substudy of EMIAT (The European Myocardial Infarct Amiodarone Trial). Malik M; Camm AJ; Janse MJ; Julian DG; Frangin GA; Schwartz PJ J Am Coll Cardiol; 2000 Apr; 35(5):1263-75. PubMed ID: 10758969 [TBL] [Abstract][Full Text] [Related]
20. Identification of post acute myocardial infarction patients with potential benefit from prophylactic treatment with amiodarone. A substudy of EMIAT (the European Myocardial Infarct Amiodarone Trial). Janse MJ; Malik M; Camm AJ; Julian DG; Frangin GA; Schwartz PJ Eur Heart J; 1998 Jan; 19(1):85-95. PubMed ID: 9503180 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]